The availability of a cell model was validated by its cancer stem-like cell features including self-renewal ability, highly migratory and invasive potentiality, stronger tumorigenicity in vivo, and high expression of cancer stem cell markers CD133, CD44, ALDH1, Nanog, and Bmi1. The gene discussed is BMI1; the disease is cancer.